Market Tracker

04/17 6:05pm ET

InterMune Inc (NASDAQ:ITMN)

28.29
Data as of Apr 17
 -0.02 / -0.07%
Today’s Change
8.61
Today|||52-Week Range
38.73
+92.06%
Year-to-Date

Today’s Trading

Previous close28.31
Today’s open28.37
Day’s range27.25 - 29.38
Volume3,639,254
Average volume (3 months)3,509,785
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)+8.26%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book19.25

Competitors

 Today’s
change
Today’s
% change
GEVASynageva BioPharma C...-0.48-0.60%
XONIntrexon Corp-0.35-1.78%
AEGRAegerion Pharmaceuti...-0.09-0.21%
IMGNImmunoGen Inc-0.22-1.55%
Data as of 4:01pm ET, 04/17/2014

Financials

Next reporting dateMay 1, 2014
EPS forecast (this quarter)-$0.62
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts